These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21512372)

  • 1. Integrating economic evaluation methods into clinical and translational science award consortium comparative effectiveness educational goals.
    Iribarne A; Easterwood R; Russo MJ; Wang YC
    Acad Med; 2011 Jun; 86(6):701-5. PubMed ID: 21512372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a multidisciplinary model of comparative effectiveness research within a clinical and translational science award.
    Marantz PR; Strelnick AH; Currie B; Bhalla R; Blank AE; Meissner P; Selwyn PA; Walker EA; Hsu DT; Shamoon H
    Acad Med; 2011 Jun; 86(6):712-7. PubMed ID: 21512360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissemination and implementation of comparative effectiveness evidence: key informant interviews with Clinical and Translational Science Award institutions.
    Morrato EH; Concannon TW; Meissner P; Shah ND; Turner BJ
    J Comp Eff Res; 2013 Mar; 2(2):185-94. PubMed ID: 24236560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
    McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
    Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can CER be an effective tool for change in the development and assessment of new drugs and technologies?
    Brixner DI; Watkins JB
    J Manag Care Pharm; 2012 Jun; 18(5 Supp A):S06-11. PubMed ID: 22663293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Training and career development for comparative effectiveness research workforce development: CTSA Consortium Strategic Goal Committee on comparative effectiveness research workgroup on workforce development.
    Kroenke K; Kapoor W; Helfand M; Meltzer DO; McDonald MA; Selker H
    Clin Transl Sci; 2010 Oct; 3(5):258-62. PubMed ID: 20973924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The implications of comparative effectiveness research for academic medicine.
    Rich EC; Bonham AC; Kirch DG
    Acad Med; 2011 Jun; 86(6):684-8. PubMed ID: 21512362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects.
    Simonds NI; Khoury MJ; Schully SD; Armstrong K; Cohn WF; Fenstermacher DA; Ginsburg GS; Goddard KA; Knaus WA; Lyman GH; Ramsey SD; Xu J; Freedman AN
    J Natl Cancer Inst; 2013 Jul; 105(13):929-36. PubMed ID: 23661804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curricular considerations for pharmaceutical comparative effectiveness research.
    Murray MD
    Pharmacoepidemiol Drug Saf; 2011 Aug; 20(8):797-804. PubMed ID: 21796716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness research - what is it and how does one do it?
    Goss CH; Tefft N
    Paediatr Respir Rev; 2013 Sep; 14(3):152-6. PubMed ID: 23890806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Translational Science Awards: opportunities and challenges for nurse scientists.
    Knafl K; Grey M
    Nurs Outlook; 2008; 56(3):132-137.e4. PubMed ID: 18501751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of comparative effectiveness research on interventional pain management: evolution from Medicare Modernization Act to Patient Protection and Affordable Care Act and the Patient-Centered Outcomes Research Institute.
    Manchikanti L; Falco FJ; Benyamin RM; Helm S; Parr AT; Hirsch JA
    Pain Physician; 2011; 14(3):E249-82. PubMed ID: 21587337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating collaborations in comparative effectiveness research: opportunities and challenges for social network analysis.
    Zickafoose JS; Kimmey LD; Tomas A; Esposito D; Rich E
    J Comp Eff Res; 2014 Nov; 3(6):667-75. PubMed ID: 25494573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness research in lung diseases and sleep disorders: recommendations from the National Heart, Lung, and Blood Institute workshop.
    Lieu TA; Au D; Krishnan JA; Moss M; Selker H; Harabin A; Taggart V; Connors A;
    Am J Respir Crit Care Med; 2011 Oct; 184(7):848-56. PubMed ID: 21965016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary competencies for comparative effectiveness research.
    Segal JB; Kapoor W; Carey T; Mitchell PH; Murray MD; Saag KG; Schumock G; Jonas D; Steinman M; Filart R; Weinberger M; Selker H
    Clin Transl Sci; 2012 Dec; 5(6):476-9. PubMed ID: 23253670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CTSA mandate: are we there yet?
    Sampselle CM; Pienta KJ; Markel DS
    Res Theory Nurs Pract; 2010; 24(1):64-73. PubMed ID: 20333913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost, coverage, and comparative effectiveness research: the critical issues for oncology.
    Pearson SD
    J Clin Oncol; 2012 Dec; 30(34):4275-81. PubMed ID: 23071229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scientific and organizational collaboration in comparative effectiveness research: the VA cooperative studies program model.
    Huang GD; Ferguson RE; Peduzzi PN; O'Leary TJ
    Am J Med; 2010 Dec; 123(12 Suppl 1):e24-31. PubMed ID: 21184863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.